What is the appropriate dosage of Compazine (chlorpromazine) oral solution?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Compazine Liquid Dosage

For severe nausea and vomiting in adults, the standard oral dosage of Compazine (prochlorperazine) liquid is 5-10 mg taken 3-4 times daily, with a maximum of 40 mg per day reserved for resistant cases. 1

Adult Dosing

For Nausea and Vomiting

  • Standard dose: 5 mg or 10 mg orally 3-4 times daily
  • Maximum daily dose: 40 mg (only in resistant cases)
  • Begin with the lowest recommended dosage and adjust based on individual response 1

The FDA-approved labeling provides clear guidance that daily dosages above 40 mg should be used only in resistant cases, establishing a firm upper limit for antiemetic use 1.

For Psychiatric Disorders

If prescribed for psychiatric conditions:

  • Non-psychotic anxiety: 5 mg 3-4 times daily (maximum 20 mg/day for no longer than 12 weeks)
  • Mild psychotic disorders: 5-10 mg 3-4 times daily
  • Moderate to severe psychotic disorders: Start 10 mg 3-4 times daily, gradually increase to 100-150 mg daily as needed 1

Pediatric Dosing

Compazine should NOT be used in children under 20 pounds or under 2 years of age 1

For children meeting weight/age requirements with severe nausea and vomiting:

  • 20-29 lbs: 2.5 mg once or twice daily (max 7.5 mg/day)
  • 30-39 lbs: 2.5 mg 2-3 times daily (max 10 mg/day)
  • 40-85 lbs: 2.5 mg 3 times daily or 5 mg twice daily (max 15 mg/day) 1

More than one day of therapy is seldom necessary in children 1.

Special Populations

Elderly Patients

  • Use dosages in the lower range
  • Increase dosage more gradually than in younger adults
  • Monitor closely for hypotension and neuromuscular reactions, as elderly patients are more susceptible 1

Debilitated or Emaciated Patients

  • Increase dosage more gradually
  • Start at the lower end of the dosing range 1

Important Clinical Considerations

Common pitfalls to avoid:

  • Do not exceed prescribed dosages, particularly in children, as adverse reaction risk increases with higher doses
  • Exercise particular caution in children with acute illnesses or dehydration due to increased dystonia risk
  • Monitor for extrapyramidal reactions, especially in children who are more prone to these effects even at moderate doses 1

The liquid formulation can be compounded extemporaneously at 100 mg/mL using chlorpromazine HCl powder dissolved in Ora-Sweet® syrup vehicle, which remains stable for at least 3 months when stored in amber plastic bottles at either refrigeration or room temperature 2. This is particularly relevant given the discontinuation of the commercial oral solution concentrate 2.

When used as breakthrough antiemetic therapy in chemotherapy patients, prochlorperazine can be dosed at 10 mg orally every 4-6 hours as needed, or 25 mg suppository every 12 hours 3, 4, 5.

References

Guideline

nccn guidelines insights: antiemesis, version 2.2017.

Journal of the National Comprehensive Cancer Network : JNCCN, 2017

Guideline

antiemesis. clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

Guideline

antiemesis.

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.